Abraxis develops a full spectrum of products used primarily in oncology, infectious diseases and critical care. Abraxis also has created, developed, and commercialized the first oncology product for the treatment of metastatic breast cancer using Abraxis’ proprietary nanoparticle technology. This innovative approach may revolutionize the treatment of cancer.